Regulatory burdens and healthcare reform are causing big uncertainties for venture capital investors. That could limit the ability of young drug and medical device companies to bring products already in the pipeline to market, thwarting billions of dollars of investment. It also could stop promising drugs, therapies, and devices from...

In a recent article about the Startup America Initiative (a public policy and programmatic priority of the Obama White House) and the Startup America Partnership (the private non-profit initiative focused on catalyzing private sector resources for entrepreneurs), I was quoted as saying "everything is moving too slowly." While...

The debt ceiling debate is over for the time being, but it sure doesn't feel like it. President Obama, the House and the Senate agreed on a compromise that increases the debt ceiling by as much as $2.4 trillion dollars. On top of the $900 billion spending cut over the...

A couple of weeks ago, the National Advisory Council on Innovation and Entrepreneurship, a council of entrepreneurs, innovators, investors, university and economic development leaders that provides policy recommendations to the White House and the Secretary of Commerce, released a report with eight specific recommendations for improving...

Laura Bennett had an idea. An actuary, Laura was aware that in the United Kingdom, almost 30 percent of pets have insurance to cover unexpected healthcare costs. In North America, the percentage is less than 1 percent. It seemed to be an unexplored market with the potential,...

Phil Brennan is a renaissance man. An Irishman who now calls Akron, Ohio home, he's been an actor, a brand manager and a Fortune 50 business leader, having launched more than 200 new products into the marketplace over the course of his career.

Since 2006, he has added "cleantech...